Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Jie Tian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9523-2271; OpenAlex author ID A5100429269. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Correction to: An ultra‑small bispecific protein augments tumor penetration and treatment for pancreatic cancer. Co-author DOI 10.1007/s00259-023-06128-0↗
  2. Decreasing hyaluronic acid combined with drug-loaded nanoprobes improve the delivery and efficacy of chemotherapeutic drugs for pancreatic cancer. Last author DOI 10.1016/j.canlet.2021.09.016↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seok Hyun Yun · 1 shared paper, 2023 · strength 0.18
  2. Qian Wang · 1 shared paper, 2023 · strength 0.18
  3. Xinming Zhao · 1 shared paper, 2023 · strength 0.18
  4. Guanhua Lu · 1 shared paper, 2021 · strength 0.14
  5. Yingfang Fan · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.